Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators two randomised clinical trials /

Background Patients with chronic obstructive pulmonary disease (COPD) have few options for treatment. The efficacy and safety of the phosphodiesterase-4 inhibitor roflumilast have been investigated in studies of patients with moderate-to-severe COPD, but not in those concomitantly treated with longa...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Fabbri Leonardo M
Calverley Peter M A
Luis Izquierdo-Alonso Jose
Bundschuh Daniela S
Brose Manja
Martinez Fernando J
Rabe Klaus F
Kollaborációs szervezet: M2-127 and M2-128 study groups
Bálint Beatrix
et al
Dokumentumtípus: Cikk
Megjelent: 2009
Sorozat:LANCET 374 No. 9691
Tárgyszavak:
doi:10.1016/S0140-6736(09)61252-6

mtmt:3410594
Online Access:http://publicatio.bibl.u-szeged.hu/30004

Hasonló tételek